Similar rate of success in Dupuytren contracture treatment between collagenase and needle fasciotomy .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up
J Bone Joint Surg Am. 2018 Jul 5;100(13):1079-1086156 patients with Dupuytren contracture of the metacarpophalangeal joint, with or without proximal interphalangeal joint involvement, were randomized to treatment with either collagenase Clostridium histolyticum (CCH) injection or percutaneous needle fasciotomy (PNF). Patients were followed-up for 2 years following treatment. Results demonstrated no significant differences between groups over 2 years in rates of correction of contractures to within 5 degrees in either MCP joints or PIP joints, as well as in rate of recurrence in either MCP joint or PIP joints. Analyses on joint range of motion and patient-reported outcome measures also demonstrated no significant differences between groups throughout follow-up.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
